Question of the Day

Arm's decision to sell chips directly is driven by several factors that outweigh the potential risk of alienating licensees. Firstly, there is significant demand for its AGI CPU, with over $2 billion anticipated for fiscal years 2027–2028, presenting substantial revenue opportunities beyond just licensing and royalties [1], [2]. By selling its own CPUs, Arm aims to capture this demand more directly, increasing its revenue per system, especially in high-demand areas like data centers [2]. However, this move changes the dynamics with its license-holding customers, as Arm transitions from being purely a licensor to a competitor in the chip manufacturing space [3]. Additionally, manufacturing and selling its chips could enhance Arm's competitive position, enabling it to offer more integrated solutions and potentially leverage its architecture to a greater extent than through licensing alone [2]. Despite these advantages, the direct competition with its licensees introduces complexities and risks, notably concerning its traditionally neutral stance in the semiconductor industry [3].